Pneumonia

Pneumonia is a leading cause of death and hospitalization, costing health care systems billions of dollars and an estimated 600,000 adult deaths worldwide each year. Pneumococcal disease is caused by the bacterium Streptococcus pneumoniae and the term describes a group of illnesses, including invasive infections, such as bacteremia/sepsis and meningitis, as well as pneumonia and upper respiratory tract infections. Although all age groups may be affected, the highest rate of pneumococcal disease occurs in young children and older adults. In addition, persons suffering from a wide range of chronic conditions (eg, diabetes, cardiovascular disease) and immune deficiencies are at increased risk.

Overview

Feature Articles

Latest Pneumonia News and Research

Inhalable nanobody shows potent anti-SARS-CoV-2 activity in vivo

Inhalable nanobody shows potent anti-SARS-CoV-2 activity in vivo

New vaccine, enhanced surveillance needed to combat childhood pneumonia

New vaccine, enhanced surveillance needed to combat childhood pneumonia

Complement system appears to be specifically implicated in severe COVID-19

Complement system appears to be specifically implicated in severe COVID-19

Electronic doctors’ notes could help hospitals plan for surges in COVID-19 cases

Electronic doctors’ notes could help hospitals plan for surges in COVID-19 cases

Basigin does not facilitate SARS-CoV-2 entry, say researchers

Basigin does not facilitate SARS-CoV-2 entry, say researchers

Corticosteroid receptor inhibitor shows anti-SARS-CoV-2 activity in vivo

Corticosteroid receptor inhibitor shows anti-SARS-CoV-2 activity in vivo

Hyperactive immune system contributes to COVID-19 severity, lung damage

Hyperactive immune system contributes to COVID-19 severity, lung damage

COVID-19 may alter host proteins to cause autoimmunity

COVID-19 may alter host proteins to cause autoimmunity

‘Resuscitating’ old antibiotics to combat the growing threat of superbugs

‘Resuscitating’ old antibiotics to combat the growing threat of superbugs

Glycan switch may explain why SARS-CoV-2 causes such variable symptoms

Glycan switch may explain why SARS-CoV-2 causes such variable symptoms

Influenza A virus defective interfering particles against SARS-CoV-2

Influenza A virus defective interfering particles against SARS-CoV-2

Failed antiviral response in nasal mucosa may predict severe COVID-19

Failed antiviral response in nasal mucosa may predict severe COVID-19

Human monoclonal antibodies can act as a substitute for traditional antibiotics

Human monoclonal antibodies can act as a substitute for traditional antibiotics

Long-term exposure to air pollution can increase cardiovascular and respiratory risks

Long-term exposure to air pollution can increase cardiovascular and respiratory risks

Chicken-derived antibody shows potent neutralizing capacity against SARS-CoV-2 in vitro

Chicken-derived antibody shows potent neutralizing capacity against SARS-CoV-2 in vitro

COVID-19 and lung cancer have a common pathway, say researchers

COVID-19 and lung cancer have a common pathway, say researchers

China's SARS and SARS-CoV-2 outbreak management in comparative perspective

China's SARS and SARS-CoV-2 outbreak management in comparative perspective

A pangolin coronavirus spike glycoprotein sheds light on SARS-CoV-2’s evolution

A pangolin coronavirus spike glycoprotein sheds light on SARS-CoV-2’s evolution

Researchers develop protocols for rapid serological surveys of SARS-CoV-2 infection

Researchers develop protocols for rapid serological surveys of SARS-CoV-2 infection

Researchers study host and viral transcriptomes in tandem to shed light on SARS-CoV-2 infection

Researchers study host and viral transcriptomes in tandem to shed light on SARS-CoV-2 infection